WebTisotumab vedotin, sold under the brand name Tivdak, is an antibody-drug conjugate used to treat cervical cancer. [1] It is a combination of tisotumab, a monoclonal antibody against … WebOct 5, 2024 · On September 20, 2024, the FDA approved tisotumab vedotin-tftv (brand name Tivdak), a tissue factor-directed antibody and microtubule inhibitor conjugate, for adult …

HIGHLIGHTS OF PRESCRIBING INFORMATION TIVDAK ...

WebDec 3, 2024 · Tivdak is a prescription medicine used to treat adults with cervical cancer: that has returned or has spread to other parts of the body, and; who have received chemotherapy that did not work or is no longer working. It is not known if … WebTIVDAK caused changes in the corneal epithelium and conjunctiva resulting in changes in vision, including severe vision loss, and corneal ulceration. Conduct an ophthalmic exam at baseline, prior to each dose, and as clinically indicated. Adhere to premedication and required eye care before, during, and after infusion. boathouse waterfront hotel kennebunk

FDA Grants Accelerated Approval for Tivdak in Previously Treated ...

WebSep 20, 2024 · Health Service Act for Tivdak (tisotumab vedotin-tftv) for injection, for intravenous use. We also refer to our accelerated approval letter dated September 20, 2024, which ... Chemotherapy in Recurrent or Metastatic Cervical Cancer” and provide the final overall survival (OS) and progression-free survival (PFS) WebOn September 20, 2024, the Food and Drug Administration granted accelerated approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc.), a tissue factor-directed antibody and … WebTIVDAK is a tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease … boat house waterfront dining in hawley pa